Literature DB >> 17336451

Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptor.

Kenneth Robzyk1, Handy Oen, Grant Buchanan, Lisa M Butler, Wayne D Tilley, Atin K Mandal, Neal Rosen, Avrom J Caplan.   

Abstract

The mechanisms underlying androgen receptor (AR)-mediated progression of prostate cancer following androgen ablation have yet to be fully determined. On this basis we screened naturally occurring mutants of human AR for hormone-independent activity using a yeast model system. An initial screen of 43 different mutants revealed that ARs having a Leu701His mutation (AR(L701H)) exhibited hormone-independent activation of a lacZ reporter gene. The AR(L701H) mutant bound dihydrotestosterone to a similar extent as did wild type AR, although its ability to be induced by hormone for transactivation was reduced substantially. Subsequent studies focused on the dependence of AR(L701H) on molecular chaperones for folding to the active state. We found that AR(L701H) was highly dependent on Hsp90 for its hormone-independent activation, suggesting that this chaperone functions in AR(L701H) folding. However, the mutant did not respond specifically to increased levels of FKBP52, suggesting that this chaperone functions at the hormone-dependent activation stage in the folding process. Further studies of AR(L701H) in PC3 cells suggested that this mutant is prohibited from hormone-independent transactivation in mammalian cells. However, basal expression of a reporter gene by AR(L701H) was not impaired by the presence of 17-allylamino-17-demethoxygeldanamycin as was wild type AR, suggesting differential interactions of these receptors with molecular chaperones in animal cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336451      PMCID: PMC1904484          DOI: 10.1016/j.mce.2007.01.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  28 in total

Review 1.  Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.

Authors:  William B Pratt; David O Toft
Journal:  Exp Biol Med (Maywood)       Date:  2003-02

2.  The "megaprimer" method of site-directed mutagenesis.

Authors:  G Sarkar; S S Sommer
Journal:  Biotechniques       Date:  1990-04       Impact factor: 1.993

3.  Characterization and expression of a cDNA encoding the human androgen receptor.

Authors:  W D Tilley; M Marcelli; J D Wilson; M J McPhaul
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 4.  Hsp90 inhibitors as novel cancer chemotherapeutic agents.

Authors:  Len Neckers
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

5.  An androgen-inducible expression system for Saccharomyces cerevisiae.

Authors:  I J Purvis; D Chotai; C W Dykes; D B Lubahn; F S French; E M Wilson; A N Hobden
Journal:  Gene       Date:  1991-09-30       Impact factor: 3.688

6.  Structural and functional consequences of glutamine tract variation in the androgen receptor.

Authors:  Grant Buchanan; Miao Yang; Albert Cheong; Jonathan M Harris; Ryan A Irvine; Paul F Lambert; Nicole L Moore; Michael Raynor; Petra J Neufing; Gerhard A Coetzee; Wayne D Tilley
Journal:  Hum Mol Genet       Date:  2004-06-15       Impact factor: 6.150

7.  The androgen receptor gene mutations database (ARDB): 2004 update.

Authors:  Bruce Gottlieb; Lenore K Beitel; Jian Hui Wu; Mark Trifiro
Journal:  Hum Mutat       Date:  2004-06       Impact factor: 4.878

8.  Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.

Authors:  M Marcelli; S Zoppi; C M Wilson; J E Griffin; M J McPhaul
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase.

Authors:  D F Nathan; S Lindquist
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

10.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

Authors:  T Visakorpi; E Hyytinen; P Koivisto; M Tanner; R Keinänen; C Palmberg; A Palotie; T Tammela; J Isola; O P Kallioniemi
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

View more
  5 in total

1.  Proteomic analysis of the androgen receptor via MS-compatible purification of biotinylated protein on streptavidin resin.

Authors:  Ryan J Austin; Heidi M Smidansky; Carly A Holstein; Deborah K Chang; Angela Epp; Neil C Josephson; Daniel B Martin
Journal:  Proteomics       Date:  2011-12-12       Impact factor: 3.984

Review 2.  Targeting the oncogene and kinome chaperone CDC37.

Authors:  Phillip J Gray; Thomas Prince; Jinrong Cheng; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Nat Rev Cancer       Date:  2008-05-30       Impact factor: 60.716

Review 3.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

4.  Androgen resistance in squirrel monkeys (Saimiri spp.).

Authors:  Katherine L Gross; Jenne M Westberry; Tina R Hubler; Patti W Sadosky; Ravinder J Singh; Robert L Taylor; Jonathan G Scammell
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 5.  Molecular cochaperones: tumor growth and cancer treatment.

Authors:  Stuart K Calderwood
Journal:  Scientifica (Cairo)       Date:  2013-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.